Administrative Core
Administrative Core
批准号:
10369068
负责人:
KEVIN O SAUNDERS
金额:
$27.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-12-17 至 2026-11-30
关键词:
AccountingAdvisory CommitteesAgreementAntibodiesAntigensB-LymphocytesBudgetsCell LineageClinical TrialsCommunicationDataData AnalysesData ProvenanceDevelopmentEnsureExpenditureExperimental DesignsFerritinFundingGoalsGrantGuidelinesHIV-1HIV-1 vaccineHumanHuman ResourcesIACUCImmune responseInfrastructureInstitutesInstitutional PolicyLeadMeasuresMonitorNational Institute of Allergy and Infectious DiseaseOccupational activity of managing financesOutcomeParticipantPhase I Clinical TrialsPoliciesPractice GuidelinesPreparationProductionProteinsProtocols documentationPublicationsRegulationReportingResearchResearch PersonnelResourcesRightsRiskSiteSupervisionTestingTimeUnited States Food and Drug AdministrationUnited States National Institutes of HealthUniversitiesVaccine ResearchVaccinesconflict resolutiondata managementdata sharingexpectationexperienceinterestmeetingsmembernanoparticlenext generation sequencingprogramsquality assurancesortasevaccine developmentvaccine platform
中文摘要
抽象行政核心
行政核心将协调IPCAVD计划的科学和管理活动,
确保项目和核心一起运作良好。特别是,它将负责管理
计划的财务管理,计划管理,并通过科学的方式协调项目和核心
会议和通信,以及确保全面遵守财务和监管规定。一项主要活动
核心的一部分将是监测IPCAVD相对于里程碑的进展,并根据
可用资金,以确保资源得到有效利用。作为具体目标,核心将提供总体
IPCAVD方案的管理、协调和监督(目标1),确保及时进行财务核算
和报告(目标2),确保遵守所有机构、州和联邦研究和cGMP指南
(目标3),制定和实施IPCAVD通信、出版和数据共享计划(目标4);
为所有数据分析提供统计支持(目标5)。核心将协调年度会议,
外部咨询委员会(EAC),将审查IPCAVD项目和核心的进展情况,并提供意见
来自DAIDS计划团队,为计划的方向提供指导。核心员工是高度
经验丰富的综合管理团队,这将使立即启动和快速进步。
这种团队合作将加速实现计划目标,从而最大限度地增加
对人类HIV-1疫苗研究产生积极影响。
英文摘要
ABSTRACT- ADMINISTRATIVE CORE
The Administrative Core will coordinate the scientific and administrative activities of this IPCAVD Program,
ensuring that the Projects and Cores function well together. In particular, it will be responsible for managing the
program’s financial management, program management, and coordinating Projects and Cores through scientific
meetings and communications, as well as ensuring full financial and regulatory compliance. A primary activity
of the Core will be monitoring IPCAVD progress relative to milestones and measuring this progress against
available funding to ensure resources are used efficiently. As Specific Aims, the Core will provide overall
IPCAVD management, coordination and supervision of the Program (Aim 1), ensure timely financial accounting
and reporting (Aim 2), ensure compliance with all institutional, state, and federal research and cGMP guidelines
(Aim 3), develop and implement IPCAVD communication, publication, and data sharing plans (Aim 4), and
provide statistical support for all data analyses (Aim 5). The Core will coordinate an annual meeting with an
External Advisory Committee (EAC) that will review the progress of IPCAVD Projects and Cores, and with input
from the DAIDS Program Team, provide guidance for the Program’s direction. Core staff are part of a highly
experienced and integrated management team, which will enable immediate start-up and rapid progress.
This teamwork will accelerate advancement toward the Program’s goals, thus maximizing the opportunities to
positively impact HIV-1 vaccine research in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Conjugate nanoparticle platform development for HIV-1 envelope immunogens
-
批准号:10541860
-
项目类别:
-
资助金额:$481.87万
-
财政年份:2021
-
负责人:KEVIN O SAUNDERS
-
依托单位:
Project 1. Optimization and in vivo evaluation of HIV-1 Env trimer sortase A-conjugated nanoparticles
-
批准号:10369069
-
项目类别:
-
资助金额:$113.16万
-
财政年份:2021
-
负责人:KEVIN O SAUNDERS
-
依托单位:
Conjugate nanoparticle platform development for HIV-1 envelope immunogens
-
批准号:10369067
-
项目类别:
-
资助金额:$471.96万
-
财政年份:2021
-
负责人:KEVIN O SAUNDERS
-
依托单位:
Administrative Core
-
批准号:10541861
-
项目类别:
-
资助金额:$25.98万
-
财政年份:2021
-
负责人:KEVIN O SAUNDERS
-
依托单位:
Project 1. Optimization and in vivo evaluation of HIV-1 Env trimer sortase A-conjugated nanoparticles
-
批准号:10541863
-
项目类别:
-
资助金额:$83.42万
-
财政年份:2021
-
负责人:KEVIN O SAUNDERS
-
依托单位:
HIV-1 vaccine-elicited antibodies target envelope glycans
-
批准号:10454824
-
项目类别:
-
资助金额:$77.44万
-
财政年份:2015
-
负责人:KEVIN O SAUNDERS
-
依托单位:
HIV-1 vaccine-elicited antibodies target envelope glycans
-
批准号:9089881
-
项目类别:
-
资助金额:$78.02万
-
财政年份:2015
-
负责人:KEVIN O SAUNDERS
-
依托单位:
HIV-1 vaccine-elicited antibodies target envelope glycans
-
批准号:10082482
-
项目类别:
-
资助金额:$81.72万
-
财政年份:2015
-
负责人:KEVIN O SAUNDERS
-
依托单位:
HIV-1 vaccine-elicited antibodies target envelope glycans
-
批准号:10674728
-
项目类别:
-
资助金额:$74.75万
-
财政年份:2015
-
负责人:KEVIN O SAUNDERS
-
依托单位:
HIV-1 vaccine-elicited antibodies target envelope glycans
-
批准号:10219934
-
项目类别:
-
资助金额:$78.98万
-
财政年份:2015
-
负责人:KEVIN O SAUNDERS
-
依托单位:
Elucidation of the Mechanisms of CD8+ T Cell Noncytolytic Antiviral Response
-
批准号:7615964
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2009
-
负责人:KEVIN O SAUNDERS
-
依托单位:
海外基金